Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by investclubon Oct 25, 2019 11:10pm
241 Views
Post# 30272175

RE:RE:RE:RE:RE:Once an IND is submitted, the FDA has 30 days to object

RE:RE:RE:RE:RE:Once an IND is submitted, the FDA has 30 days to objectLongholder99 wrote 
 I've thought it would be the last few events that would take us up. I think the speculative retail money is fried on the weed explosion. Very wary and lots lost. This last financing has been a kick in the knackers short term. But a blessing big picture. I'm not even a bit worried about this investment. I'm in way too heavy but you only live once and this is a once in a lifetime investment. Ask yourself. What do YOU think the next big step in Oncology treatment will be after PDC? .....and how long will it take to get itself to Phase 2b? See you in 50+ years maybe.

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx 

Longholder99 your words ring load and true "" this is a once in a lifetime investment "" . 
Will we see the next big step in oncology treatment?  ...  Really Longholder99 no I don't honestly not even the youngest investor here will live long enough but maybe our children might see something as remarkable as the medical mark Theralase will leave in relieving victims of the anguish that cancer can cause. First they must prove to the world this now 2 treatment process works with extremely high CR percentage with little to no healthy cell damage then quickly move into the next indications. This is history unfolding   .... cheers to the next gold standard in cancer destruction 
Bullboard Posts